Has the decline in U.S. publicly listed companies reversed?
Core argument: U.S. publicly listed companies rose 28% from 4,144 in August 2020 to 5,301 in December 2021, with Special Purpose Acquisition Companies (SPACs) accounting for 53% of new listings over that period.
In the wake of the COVID-19 pandemic, the U.S. equity markets experienced a significant surge in publicly listed companies, with numbers rising from 4,144 in August 2020 to 5,301 by December 2021, marking a 28% increase. This growth was driven by the popularity of Special Purpose Acquisition Companies (SPACs), which accounted for 53% of new listings during this period. The SPAC phenomenon altered market composition, with small-size SPAC stocks increasing from 8% to 28% and foreign-incorporated shares rising from 14% to 18%. Despite the SPAC influence, traditional IPOs also contributed to the boom, with non-SPAC listings growing at an annualized rate of 7.5%, a stark contrast to the -2.8% rate from 1997 to 2020. This post-COVID environment, characterized by low interest rates and ample liquidity, proved favorable for new IPOs, reshaping the U.S. equity landscape.









